Steroids in idiopathic pulmonary fibrosis: a prospective assessment of adverse reactions, response to therapy, and survival. (Q53896108)

22 May 2018

title

Steroids in idiopathic pulmonary fibrosis: a prospective assessment of adverse reactions, response to therapy, and survival. (English)

1 reference

22 May 2018

idiopathic pulmonary fibrosis

1 reference

1 reference

Flaherty KR

1

1 reference

22 May 2018

Toews GB

2

1 reference

22 May 2018

Lynch JP 3rd

3

1 reference

22 May 2018

Kazerooni EA

4

1 reference

22 May 2018

Gross BH

5

1 reference

22 May 2018

Strawderman RL

6

1 reference

22 May 2018

Hariharan K

7

1 reference

22 May 2018

Flint A

8

1 reference

22 May 2018

Martinez FJ

9

1 reference

22 May 2018

language of work or name

English

0 references

publication date

1 March 2001

1 reference

22 May 2018

American Journal of Medicine

published in

1 reference

22 May 2018

volume

110

1 reference

22 May 2018

issue

4

1 reference

22 May 2018

page(s)

278-282

1 reference

22 May 2018

Corticosteroids and the treatment of idiopathic pulmonary fibrosis. Past, present, and future

cites work

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(00)00711-7

American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(00)00711-7

Idiopathic pulmonary fibrosis: Impact of oxygen and colchicine, prednisone, or no therapy on survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(00)00711-7

Chronic Diffuse Interstitial Fibrosis of the Lungs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(00)00711-7

A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(00)00711-7

Thin-section CT obtained at 10-mm increments versus limited three-level thin-section CT for idiopathic pulmonary fibrosis: correlation with pathologic scoring

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(00)00711-7

Influence of sample number and biopsy site on the histologic diagnosis of diffuse lung disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(00)00711-7

Quantitative assessment of lung pathology in idiopathic pulmonary fibrosis. The BAL Cooperative Group Steering Committee.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(00)00711-7

Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(00)00711-7

Idiopathic pulmonary fibrosis: predicting response to therapy and survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(00)00711-7

Corticosteroid Treatment of Diffuse Interstitial Pulmonary Fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(00)00711-7

The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: A prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(00)00711-7

Oxygen cost of breathing in patients with emphysema or chronic bronchitis in acute respiratory failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(00)00711-7

Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(00)00711-7

Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(00)00711-7

10.1016/S0002-9343(00)00711-7

7 January 2021

Identifiers

DOI

1 reference

22 May 2018

1 reference

22 May 2018